LYTIR

Company · XGN

Exagen Inc.

Name as listed on its exchange; filed with the SEC as EXAGEN INC.

Nasdaq's symbol directory lists XGN on Nasdaq as “Exagen Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($104K); insiders sold on 2 occasions ($419K).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $104K in total; Insider sales: $419K in total.Sep: Insider sales $149KOct: Insider purchases $104KOct: Insider sales $270KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $104KInsider sales below: $419K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. ABALLI JOHN, President and CEO sold on 1 day latest Oct 16, 2026 sold $270K
  2. Black Jeffrey G., Chief Financial Officer sold on 1 day latest Sep 1, 2026 sold $149K
  3. Jorey Chernett bought on 1 day latest Oct 19, 2026 bought $104K
Every trade (3)
  1. BUYJorey Chernett bought Oct 19, 2026 14,000 shares filing $104K
  2. SELLABALLI JOHN, President and CEO sold Oct 16, 2026 34,294 shares filing $270K
  3. SELLBlack Jeffrey G., Chief Financial Officer sold Sep 1, 2026 20,614 shares filing $149K

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.